It has been estimated that ∼50% of AD patients also have αSyn pathology, and conversely a similar percentage of PD patients have tau copathology (Irwin and Hurtig, 2018; Robinson et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.